InvestorsHub Logo
Followers 13
Posts 4300
Boards Moderated 0
Alias Born 10/27/2020

Re: None

Tuesday, 06/14/2022 6:06:06 PM

Tuesday, June 14, 2022 6:06:06 PM

Post# of 59
Awakn Life Sciences Completes World's First Ketamine Treatment Study for a Range of Behavioral Addictions. Promising Results Merit Larger Study Which Awakn is Initiating. $AWKNF